The FDA now requires new warnings on carbidopa/levodopa labels about vitamin B6 deficiency and possible seizures, with advice on testing and monitoring.
A new Alzheimer’s blood-test model may help researchers estimate when symptoms begin, but it is not ready for routine use or screening in healthy adults.
New Alzheimer’s blood tests are becoming part of clinical care in the United States, but they are not simple screening tools for anyone worried about forgetfulness. Here’s what the FDA cleared, what specialists recommend, and what families should ask before treating a blood result as proof of Alzheimer’s disease.
FDA-approved anti-amyloid drugs such as lecanemab are now in real-world use for early Alzheimer’s disease. Here’s who qualifies, what the main clinical trial showed, what ARIA risks mean, and how Medicare coverage works in the United States.
FDA traditional approval of lecanemab for early Alzheimer’s disease offers modest slowing of decline for some patients—but requires careful screening, MRI monitoring, and meeting Medicare coverage rules. Here’s what families should understand in 2026.
Using headache medicines too often can sometimes make headaches worse instead of better. Here’s what U.S. experts say about medication overuse headache—how it happens, who’s at risk, and how to break the cycle safely.
Anti-amyloid antibody treatments such as lecanemab are now part of Alzheimer’s care in the United States—but only for certain patients. Here’s who qualifies, what Medicare covers, how MRI safety monitoring works, and what families should realistically expect.
A rare condition called congenital insensitivity to pain may sound like a superpower. In reality, it can be life-threatening. Here’s what researchers know, what remains a mystery, and what it means for everyday health.
ADHD remains one of the most common childhood neurodevelopmental conditions in the United States. Here’s what current guidance says about symptoms, diagnosis, treatment options, and what it means for families and adults living with ADHD.
ADHD remains one of the most common neurodevelopmental conditions in the United States. Here’s what current public health guidance and medical research say about symptoms, treatment options, medication safety, and what families should know.
Dementia affects millions of Americans, and new treatments and prevention research continue to evolve. Here’s what families should understand about early signs, risk factors, available medications, and what remains uncertain.
Most headaches are not dangerous, but some need medical attention. Here’s how to tell the difference, what current guidance says about treatment, and when to see a doctor.
Stroke remains a leading cause of death and long-term disability in the United States. Here’s what the latest public health guidance says about symptoms, treatment timing, risk factors, and practical prevention steps.
This article explains the early warning signs of neurological problems—such as persistent or unusual headaches, new numbness or weakness (especially on one side), balance or coordination issues, vision or speech changes, memory lapses, personality shifts, tremors, or seizures—and why they shouldn’t be ignored. It highlights red flags that warrant urgent care, including sudden face drooping, arm weakness, or speech difficulty (possible stroke), and severe, abrupt headaches. Readers will learn practical steps like tracking symptoms, noting triggers and timelines, and knowing when to contact a clinician, plus what to expect from evaluation and testing. The key value is empowering patients and caregivers with clear, reliable guidance to recognize symptoms early, seek timely care, and improve the chances of effective treatment and safer outcomes.
This article explains what neurological disorders are—conditions that affect the brain, spinal cord, and nerves—and how they disrupt communication in the nervous system to impact movement, sensation, thinking, and mood. It outlines common conditions such as stroke, epilepsy, migraine, Parkinson’s disease, multiple sclerosis, dementia, neuropathy, and traumatic brain injury, describing typical symptoms and when to seek care. Readers learn how these disorders are diagnosed (history, exams, imaging, and tests) and treated through medications, rehabilitation, devices, surgery, and lifestyle strategies. With a supportive, plain-language approach, it offers practical guidance for patients and caregivers to recognize warning signs, prepare for appointments, ask informed questions, and find credible resources for ongoing support.
This article offers a clear, step-by-step guide to how neurological disorders are diagnosed, helping patients and caregivers understand what to expect and why each test matters. It covers the initial medical history and neurological exam, then explains common tools such as MRI and CT scans for brain and spine imaging, EEG for electrical brain activity, EMG and nerve conduction studies for nerves and muscles, lumbar puncture, blood and genetic tests, and cognitive assessments. Readers learn when each test is used, how to prepare, safety and comfort considerations, and how results guide treatment decisions. Practical tips support better communication with clinicians, reduce anxiety about testing, and empower informed choices throughout the diagnostic journey.
This article offers a clear, patient-centered overview of the most important neurological treatment advances in 2025—covering conditions like Alzheimer’s, Parkinson’s, multiple sclerosis, epilepsy, migraine, stroke recovery, and ALS. It explains how new options such as gene and cell therapies, disease‑modifying drugs, targeted antibodies, next‑generation neuromodulation, digital therapeutics, and AI‑guided diagnostics are changing care, with an emphasis on who might benefit, expected outcomes, and common side effects. You’ll find practical guidance on eligibility, safety monitoring, access and insurance considerations, and how to evaluate clinical trials and real‑world evidence. The article also highlights personalized care plans, remote symptom tracking, and rehabilitation supports, plus resources for caregivers and mental health. Most importantly, it equips patients and families with questions to ask their care team and tips for shared decision‑making, so you can confidently navigate new treatments and choose what aligns with your goals and values.
This article clearly explains how Parkinson’s, Alzheimer’s, and other common neurological disorders differ in symptoms, progression, diagnosis, and treatment, helping readers recognize what to watch for and when to seek care. It breaks down hallmark signs—such as movement changes in Parkinson’s and memory decline in Alzheimer’s—while addressing overlaps that can cause confusion. You’ll find practical guidance on evaluation steps, medication and non‑drug therapies, daily living strategies, and support resources for patients and caregivers. The goal is to reduce uncertainty, promote earlier intervention, and empower informed conversations with healthcare professionals.
Explore symptoms, diagnosis, and treatment options in our comprehensive guide to multiple sclerosis.
Learn to identify stroke symptoms early with our comprehensive and professional guide.
Discover how neuroplasticity revolutionizes recovery and healing in modern medicine.
Explore symptoms, treatments, and insights in our in-depth guide to Parkinson’s Disease.
End of content
End of content
